跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LECTEVA levodopa/carbidopa/entacapone 200 mg/50 mg/200 mg tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
LECTEVA levodopa/carbidopa/entacapone 200 mg/50 mg/200 mg tablet bottle
Approved
STANDARD
LECTEVA levodopa/carbidopa/entacapone 200 mg/50 mg/200 mg tablet bottle
Teva Pharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 28, 2025
Approval ID
070512fecea4db45
Company
Teva Pharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
070512fecea4db45
Product Name
LECTEVA levodopa/carbidopa/entacapone 200 mg/50 mg/200 mg tablet bottle
Artg Id
238866
Artg Name
LECTEVA levodopa/carbidopa/entacapone 200 mg/50 mg/200 mg tablet bottle
Sponsor
Teva Pharma Australia Pty Ltd
Company Detail Path
/organization/teva-pharma-australia-pty-ltd
Artg Date
2016-04-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/0b5a0319bdb8c5c31b7b534d44a3a211.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/51bb34b88b276dca2b5a8e49fbd78251.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 28, 2025
Approval ID
070512fecea4db45
Type
Standard
Back to TGA Approvals